As shown in Figure 3A, we found that high expressions of SFRP1, SAA1 and RBP4 were related to favorable long-term survival in BC patients, while high expression of KIF4A, UBE2C and COL11A1 was associated with poor prognosis in BC patients (Figure 3B). This evidence concerns the gene UBE2C and breast cancer.